DK0944617T3 - Krystaller af benzimidazolderivater og deres fremstilling - Google Patents

Krystaller af benzimidazolderivater og deres fremstilling

Info

Publication number: DK0944617T3
Authority: DK; Denmark
Prior art keywords: substituted; optionally; crystals; preparation; benzimidazole derivatives
Prior art date: 1996-11-14

Application number

DK97912445T

Other languages

English (en)

Inventor

Masayasu Kato

Toru Ishida

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-14

Filing date

1997-11-13

Publication date

2003-09-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17920069&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0944617(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-11-13 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

2003-09-01 Application granted granted Critical

2003-09-01 Publication of DK0944617T3 publication Critical patent/DK0944617T3/da

Links

239000013078 crystal Substances 0.000 title abstract 2
229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
125000003545 alkoxy group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
125000005843 halogen group Chemical group 0.000 abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK97912445T 1996-11-14 1997-11-13 Krystaller af benzimidazolderivater og deres fremstilling DK0944617T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP30336196		1996-11-14
PCT/JP1997/004136 WO1998021201A1 (en)	1996-11-14	1997-11-13	Crystals of benzimidazole derivatives and their production

Publications (1)

Publication Number	Publication Date
DK0944617T3 true DK0944617T3 (da)	2003-09-01

Family

ID=17920069

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97912445T DK0944617T3 (da)	1996-11-14	1997-11-13	Krystaller af benzimidazolderivater og deres fremstilling

Country Status (18)

Country	Link
US (1)	US6002011A (da)
EP (1)	EP0944617B1 (da)
KR (1)	KR100519576B1 (da)
CN (2)	CN100355749C (da)
AT (1)	ATE240314T1 (da)
AU (1)	AU731776B2 (da)
CA (1)	CA2269053C (da)
DE (1)	DE69722027T2 (da)
DK (1)	DK0944617T3 (da)
ES (1)	ES2199356T3 (da)
ID (1)	ID21547A (da)
IL (1)	IL129724A (da)
NZ (1)	NZ335145A (da)
PT (1)	PT944617E (da)
TR (1)	TR199901055T2 (da)
TW (1)	TW385306B (da)
WO (1)	WO1998021201A1 (da)
ZA (1)	ZA9710255B (da)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW385306B (en) *	1996-11-14	2000-03-21	Takeda Chemical Industries Ltd	Method for producing crystals of benzimidazole derivatives
UA72748C2 (en)	1998-11-10	2005-04-15	Astrazeneca Ab	A novel crystalline form of omeprazole
IL142703A (en)	1998-11-10	2006-04-10	Astrazeneca Ab	Crystalline form of omeprazole
JP3926936B2 (ja)	1998-11-16	2007-06-06	エーザイ・アール・アンド・ディー・マネジメント株式会社	スルホキシド誘導体・アセトン錯体およびその製造法
WO2000045851A2 (de) *	1999-02-04	2000-08-10	Bullerdiek Joern	Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs
US7110444B1 (en)	1999-08-04	2006-09-19	Parkervision, Inc.	Wireless local area network (WLAN) using universal frequency translation technology including multi-phase embodiments and circuit implementations
TWI289557B (en) *	1999-06-17	2007-11-11	Takeda Chemical Industries Ltd	A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PL333847A1 (en) *	1999-06-18	2001-01-02	Inst Farmaceutyczny	Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
AU5705700A (en)	1999-06-30	2001-01-22	Takeda Chemical Industries Ltd.	Crystals of benzimidazole compounds
EP1293507B1 (en) *	2000-05-15	2007-11-28	Takeda Pharmaceutical Company Limited	Process for producing crystal
CA2417311C (en)	2000-08-04	2012-07-10	Takeda Chemical Industries, Ltd.	Crystalline alkali metal salts of lansoprazole and their production and use
CA2419067C (en)	2000-08-18	2008-12-23	Takeda Chemical Industries, Ltd.	Injectable composition comprising benzimidazole compound and strong alkali
KR20100002278A (ko)	2000-12-01	2010-01-06	다케다 야쿠힌 고교 가부시키가이샤	(ｒ)- 또는 (ｓ)-란소프라졸의 결정
DE10140492A1 (de)	2001-08-17	2003-08-14	Gruenenthal Gmbh	Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
US8105626B2 (en)	2001-10-17	2012-01-31	Takeda Pharmaceutical Company Limited	Granules containing acid-unstable chemical in large amount
MXPA04007995A (es) *	2002-02-19	2004-11-26	Teva Pharma	Desolvatacion de solvatos de hemicalcio de atorvastatina.
AU2003224779A1 (en) *	2002-03-27	2003-10-13	Teva Pharmaceutical Industries Ltd.	Lansoprazole polymorphs and processes for preparation thereof
KR100873419B1 (ko) *	2002-06-18	2008-12-11	페어차일드코리아반도체 주식회사	높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자
TW200410955A (en)	2002-07-29	2004-07-01	Altana Pharma Ag	Novel salt of (S)-PANTOPRAZOLE
ATE375338T1 (de) *	2002-08-21	2007-10-15	Teva Pharma	Verfahren zur aufreinigung von lanzoprazol
EP1764364A1 (en) *	2002-08-21	2007-03-21	Teva Pharmaceutical Industries Ltd	A method for the purification of lansoprazole
MY148805A (en)	2002-10-16	2013-05-31	Takeda Pharmaceutical	Controlled release preparation
EP1552833B1 (en)	2002-10-16	2016-12-28	Takeda Pharmaceutical Company Limited	Process for producing an amorphous optically active isomer of lansoprazole
EP1743893A1 (en)	2002-11-18	2007-01-17	Teva Pharmaceutical Industries Ltd.	Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
EP1465890B1 (en) *	2002-11-18	2007-04-04	Teva Pharmaceutical Industries Ltd.	Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
US7678816B2 (en) *	2003-02-05	2010-03-16	Teva Pharmaceutical Industries Ltd.	Method of stabilizing lansoprazole
US7005732B2 (en) *	2003-10-21	2006-02-28	Honeywell International Inc.	Methods and systems for providing MEMS devices with a top cap and upper sense plate
TW200526268A (en) *	2003-12-17	2005-08-16	Takeda Pharmaceutical	Injectable composition
SE0400410D0 (sv) *	2004-02-20	2004-02-20	Astrazeneca Ab	New compounds
EP1768668A2 (en)	2004-06-16	2007-04-04	Tap Pharmaceutical Products, Inc.	Multiple ppi dosage form
EP1790647B1 (en)	2004-09-13	2013-05-08	Takeda Pharmaceutical Company Limited	Method for producing oxidized compound
EP1681056A1 (en) *	2005-01-14	2006-07-19	Krka Tovarna Zdravil, D.D., Novo Mesto	Process for preparing lansoprazole
EP2275088B2 (en)	2005-02-25	2018-09-26	Takeda Pharmaceutical Company Limited	Method for producing granules
WO2006132217A1 (ja) *	2005-06-07	2006-12-14	Takeda Pharmaceutical Company Limited	ベンズイミダゾール化合物の塩の結晶
EP1903039A4 (en) *	2005-06-13	2010-09-22	Takeda Pharmaceutical	INJECTION
WO2007074909A1 (ja)	2005-12-28	2007-07-05	Takeda Pharmaceutical Company Limited	放出制御固形製剤
KR100758600B1 (ko) *	2006-01-05	2007-09-13	주식회사 대웅제약	란소프라졸 결정형 ａ의 제조방법
WO2008035189A1 (en) *	2006-09-22	2008-03-27	Orchid Chemicals & Pharmaceuticals Limited	A method for the purification of lansoprazole
WO2008068767A2 (en) *	2006-12-07	2008-06-12	Hetero Drugs Limited	A novel crystalline form of lansoprazole
ITMI20062481A1 (it) *	2006-12-22	2008-06-23	Recordati Chem Pharm	Processo per la preparazione di lansoprazolo forma i microcristallino
JP5366558B2 (ja)	2006-12-28	2013-12-11	武田薬品工業株式会社	口腔内崩壊性固形製剤
EP2573082A1 (en) *	2007-12-31	2013-03-27	Takeda Pharmaceutical Company Limited	Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole
AU2009224247B2 (en) *	2008-03-10	2013-12-12	Takeda Pharmaceutical Company Limited	Crystal of benzimidazole compound
WO2011004387A2 (en)	2009-06-18	2011-01-13	Matrix Laboratories Ltd	Process for the preparation of dexlansoprazole polymorphic forms
WO2011098938A1 (en) *	2010-02-11	2011-08-18	Orchid Chemicals And Pharmaceuticals Limited	Novel solvate of dexlansoprazole
WO2012074110A1 (ja)	2010-12-03	2012-06-07	武田薬品工業株式会社	口腔内崩壊錠
US20130273157A1 (en)	2010-12-27	2013-10-17	Takeda Pharmaceutical Company Limited	Orally disintegrating tablet
CN102180866B (zh) *	2011-05-23	2013-03-13	中山大学	兰索拉唑晶型及其制备方法和应用
CN103012369B (zh) *	2011-05-23	2014-04-23	中山大学	兰索拉唑n晶型及其制备方法和应用
CA2857457C (en)	2011-11-30	2018-05-01	Takeda Pharmaceutical Company Limited	Dry coated tablet
US9119769B2 (en)	2011-12-30	2015-09-01	The Curators Of The University Of Missouri	Method for transforming pharmaceutical crystal forms
SG11201509439SA (en)	2013-05-21	2015-12-30	Takeda Pharmaceutical	Orally disintegrable tablet
CN103539729A (zh) *	2013-10-14	2014-01-29	安徽国星生物化学有限公司	一种氯甲基吡啶衍生物的工业化生产方法
CN103539728A (zh) *	2013-10-14	2014-01-29	安徽国星生物化学有限公司	一种拉唑类药物中间体氯甲基吡啶衍生物的合成方法
CN104829594A (zh) *	2015-05-15	2015-08-12	苗怡文	一种治疗胃溃疡的药物兰索拉唑化合物
CN104817492B (zh) *	2015-05-22	2018-05-18	抚州三和医药化工有限公司	兰索拉唑中间体2-羟甲基-3-甲基-4-(2,2,2-三氟乙氧基）吡啶的分离纯化方法
KR102649498B1 (ko)	2023-12-06	2024-03-20	거산해운(주)	선사별 실시간 통합 예약 정보를 기반으로 한 화주의 해상 운송 예약 자동화 플랫폼 서비스 제공 방법, 장치 및 시스템

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv) *	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
JPS6150978A (ja) *	1984-08-16	1986-03-13	Takeda Chem Ind Ltd	ピリジン誘導体およびその製造法
DK171989B1 (da) *	1987-08-04	1997-09-08	Takeda Chemical Industries Ltd	Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
DE4018642C2 (de) *	1990-06-11	1993-11-25	Byk Gulden Lomberg Chem Fab	Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
SE9302395D0 (sv) *	1993-07-09	1993-07-09	Ab Astra	New pharmaceutical formulation
SE9302396D0 (sv) *	1993-07-09	1993-07-09	Ab Astra	A novel compound form
US5374730A (en) *	1993-11-04	1994-12-20	Torcan Chemical Ltd.	Preparation of omeprazole and lansoprazole
GB2297550C2 (en) *	1995-02-06	1997-04-09	Smithkline Beecham Plc	Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
TW385306B (en) *	1996-11-14	2000-03-21	Takeda Chemical Industries Ltd	Method for producing crystals of benzimidazole derivatives

1997
- 1997-11-05 TW TW086116425A patent/TW385306B/zh not_active IP Right Cessation
- 1997-11-13 WO PCT/JP1997/004136 patent/WO1998021201A1/en not_active Ceased
- 1997-11-13 DE DE69722027T patent/DE69722027T2/de not_active Expired - Lifetime
- 1997-11-13 TR TR1999/01055T patent/TR199901055T2/xx unknown
- 1997-11-13 CN CNB200410078970XA patent/CN100355749C/zh not_active Expired - Lifetime
- 1997-11-13 ES ES97912445T patent/ES2199356T3/es not_active Expired - Lifetime
- 1997-11-13 AU AU49652/97A patent/AU731776B2/en not_active Ceased
- 1997-11-13 IL IL12972497A patent/IL129724A/en not_active IP Right Cessation
- 1997-11-13 ID IDW990304A patent/ID21547A/id unknown
- 1997-11-13 CN CNB971996385A patent/CN1171885C/zh not_active Expired - Lifetime
- 1997-11-13 KR KR10-1999-7004094A patent/KR100519576B1/ko not_active Expired - Lifetime
- 1997-11-13 DK DK97912445T patent/DK0944617T3/da active
- 1997-11-13 ZA ZA9710255A patent/ZA9710255B/xx unknown
- 1997-11-13 EP EP97912445A patent/EP0944617B1/en not_active Expired - Lifetime
- 1997-11-13 CA CA002269053A patent/CA2269053C/en not_active Expired - Lifetime
- 1997-11-13 PT PT97912445T patent/PT944617E/pt unknown
- 1997-11-13 NZ NZ335145A patent/NZ335145A/xx not_active IP Right Cessation
- 1997-11-13 AT AT97912445T patent/ATE240314T1/de active
1998
- 1998-01-21 US US09/009,959 patent/US6002011A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IL129724A (en)	2004-02-19
AU731776B2 (en)	2001-04-05
AU4965297A (en)	1998-06-03
ATE240314T1 (de)	2003-05-15
IL129724A0 (en)	2000-02-29
WO1998021201A1 (en)	1998-05-22
CA2269053A1 (en)	1998-05-22
NZ335145A (en)	2000-12-22
CN1237167A (zh)	1999-12-01
TW385306B (en)	2000-03-21
HK1020194A1 (en)	2000-03-31
CN1171885C (zh)	2004-10-20
CA2269053C (en)	2006-07-18
PT944617E (pt)	2003-08-29
EP0944617A1 (en)	1999-09-29
US6002011A (en)	1999-12-14
ID21547A (id)	1999-06-24
ES2199356T3 (es)	2004-02-16
DE69722027T2 (de)	2004-03-25
CN1616457A (zh)	2005-05-18
EP0944617B1 (en)	2003-05-14
TR199901055T2 (xx)	1999-07-21
KR100519576B1 (ko)	2005-10-07
ZA9710255B (en)	1999-05-13
DE69722027D1 (de)	2003-06-18
CN100355749C (zh)	2007-12-19
KR20000053158A (ko)	2000-08-25

Publication	Publication Date	Title
PT944617E (pt)	2003-08-29	Cristais de derivados de benzimidazole e sua producao
HUP9802859A2 (hu)	1999-03-29	Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
YU46916B (sh)	1994-06-24	Postupak za dobijanje kalcijum nezavisnih camp inhibitora fosfodiesteraze
DK0487071T3 (da)	1995-10-30	Kondenserede heterocykliske forbindelser, deres fremstilling og anvendelse
DK0383449T3 (da)	1996-01-02	Heterocykliske forbindelser
CA1272482C (en)	1990-08-07	QUINOLINECARBOXYLIC ACID DERIVATIVES
EA199800759A1 (ru)	1999-04-29	2-гетароилциклогексан-1,3-дионы
UA66756C2 (uk)	2004-06-15	Сполуки піперазину та піперидину, спосіб одержання сполук та спосіб лікування розладів центральної нервової системи
ES8609204A1 (es)	1986-09-01	Procedimiento de preparar derivados aminicos
NO964698L (no)	1996-11-06	Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
DE3776044D1 (de)	1992-02-27	Pyridazinon-derivate.
NO892170D0 (no)	1989-05-30	Buten- eller propensyrederivater og fremgangsmaate for deres fremstilling.
NO960441L (no)	1996-02-02	Benzopyraner og farmasöytiske forbindelser inneholdende dem
DK0819108T3 (da)	2001-11-26	Fremgangsmåde til fremstilling af galanthaminderivater ved asymmetrisk reduktion
NO20073213L (no)	2007-09-19	Fremgangsmate for fremstilling av tiofenglykosidderivater
NO961537L (no)	1996-10-21	Salpetersyreestere fra derivater av 2-(2,6-dihalofenylamino)-fenylacetoksyeddiksyre, og deres fremstillingsprosedyrer
NO890158D0 (no)	1989-01-13	Fremgangsmaate for fremstilling av hydroksialkyleringsmiddel, de oppnaadde midler og deres anvendelse.
PT99280A (pt)	1992-08-31	Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
DK369289A (da)	1990-01-27	Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
DK0413278T3 (da)	1997-04-07	Anvendelse af xanthinderivater mod mavesår
ES2040223T3 (es)	1993-10-16	Derivados de la tiadiazolilacetamida, procedimiento para su fabricacion y su utilizacion.
NO954764L (no)	1996-01-25	Psoralen-derivater, deres fremstilling og anvendelse
ATE19629T1 (de)	1986-05-15	N-substituierte derivate des tetrahydroisophthalimids.
DK231787D0 (da)	1987-05-06	3-amino-dihydropyridiner, fremgangsmaade til deres fremstilling og deres anvendelse i laegemidler
MY104164A (en)	1994-02-28	Heterocyclic compounds.